andrea.av@usal.es
I obtained a BSc in Biochemistry at the Universidad de Castilla-La Mancha (Toledo) in 2017. I performed my BSc thesis in the Neuroinflammation Unit at the Instituto de Salud Carlos III, where I studied the immune microenvironment of gliomas. Then I obtained a MSc in Neuroscience at the Universidad de Salamanca (2017-2018). During my MSc thesis, I joined the Neurobiochemistry group at the Instituto de Neurociencias de Castilla y León (INCyL), led by Dr. Arantxa Tabernero, where I studied the effect of an anti-tumour cell penetrating peptide based on connexin43 in neural stem cells from the subventricular zone in an in vivo glioma model. In 2019, I obtained a fellowship from the Junta de Castilla y León that’s allowing me to pursue my PhD in Neuroscience in the lab. I defended my PhD thesis ”Translational steps towards the clinical application of TAT-Cx43266-283 for the treatment of glioblastoma: EGFR as a predictor and mediator of treatment response, and positive results in combination with tumor resection in a preclinical model” in 2024.
Aún no hay comentarios.